Publikationer av Cecilia Williams

Refereegranskade

Artiklar

[1]

M. Birgersson et al., "ERβ in Granulosa Cell Tumors and Its Clinical Potential," Endocrinology, vol. 164, no. 6, 2023.

[2]

L. Hases et al., "High-fat diet and estrogen modulate the gut microbiota in a sex-dependent manner in mice," Communications Biology, vol. 6, no. 1, 2023.

[3]

M. Perez-Zabaleta et al., "Long-term SARS-CoV-2 surveillance in the wastewater of Stockholm : What lessons can be learned from the Swedish perspective?," Science of the Total Environment, vol. 858, 2023.

[4]

Y. Cheng et al., "NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation," Protein & Cell, vol. 14, no. 2, s. 123-136, 2023.

[5]

M. Birgersson et al., "Ovarian ERβ cistrome and transcriptome reveal chromatin interaction with LRH-1," BMC Biology, vol. 21, no. 1, 2023.

[6]

S. Jain et al., "Sensing of protein and DNA complexes using solid-state nanopores," Biophysical Journal, vol. 122, no. 3S1, 2023.

[7]

A. C. Vivekanand et al., "Statistical Analysis of SARS-CoV-2 Using Wastewater-Based Data of Stockholm, Sweden," International Journal of Environmental Research and Public Health, vol. 20, no. 5, 2023.

[8]

S. Thrikawala et al., "Triazole fungicides induce adipogenesis and repress osteoblastogenesis in zebrafish," Toxicological Sciences, vol. 193, no. 2, s. 119-130, 2023.

[9]

F. L. Monteiro, C. Williams och L. A. Helguero, "A Systematic Review to Define the Multi-Faceted Role of Lysine Methyltransferase SETD7 in Cancer," Cancers, vol. 14, no. 6, s. 1414, 2022.

[10]

R. Indukuri, A. Damdimopoulos och C. Williams, "An Optimized ChIP-Seq Protocol to Determine Chromatin Binding of Estrogen Receptor Beta.," Methods in Molecular Biology, vol. 2418, s. 203-221, 2022.

[11]

M. Birgersson et al., "Antibody Validation for Estrogen Receptor Beta," Methods in Molecular Biology, vol. 2418, s. 1-23, 2022.

[12]

L. Hases et al., "Colitis Induces Sex-Specific Intestinal Transcriptomic Responses in Mice," International Journal of Molecular Sciences, vol. 23, no. 18, s. 10408, 2022.

[13]

D. Song et al., "ER alpha and ER beta Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions," Frontiers in Endocrinology, vol. 13, 2022.

[14]

D. Huang et al., "Estrogen Receptor beta (ESR2) Transcriptome and Chromatin Binding in a Mantle Cell Lymphoma Tumor Model Reveal the Tumor-Suppressing Mechanisms of Estrogens," Cancers, vol. 14, no. 13, s. 3098, 2022.

[15]

A. Archer, C. Kutter och C. Williams, "Expression Profiles of Estrogen-Regulated MicroRNAs in Cancer Cells.," Methods in Molecular Biology, vol. 2418, s. 313-343, 2022.

[16]

F. L. Monteiro et al., "SETD7 Expression Is Associated with Breast Cancer Survival Outcomes for Specific Molecular Subtypes : A Systematic Analysis of Publicly Available Datasets," Cancers, vol. 14, no. 24, s. 6029, 2022.

[17]

M. Hakim Jaffer Ali et al., "Benchmarking virus concentration methods for quantification of SARS-CoV-2 in raw wastewater," Science of the Total Environment, vol. 755, 2021.

[18]

D. Song et al., "Blocking Fra-1 sensitizes triple-negative breast cancer to PARP inhibitor," Cancer Letters, vol. 506, s. 23-34, 2021.

[19]

R. Indukuri et al., "Estrogen Receptor Beta Influences the Inflammatory p65 Cistrome in Colon Cancer Cells," Frontiers in Endocrinology, vol. 12, s. 1-13, 2021.

[20]

R. Indukuri et al., "Genome-wide estrogen receptor β chromatin binding in humancolon cancer cells reveals its tumor suppressor activity," International Journal of Cancer, 2021.

[21]

Q. Liu et al., "Menopausal hormone therapies and risk of colorectal cancer : a Swedish matched-cohort study.," Alimentary Pharmacology and Therapeutics, vol. 53, no. 11, s. 1216-1225, 2021.

[22]

J. Simin et al., "Prediagnostic use of estrogen-only therapy is associated with improved colorectal cancer survival in menopausal women : a Swedish population-based cohort study," Acta Oncologica, vol. 60, no. 7, s. 881-887, 2021.

[23]

L. Hases et al., "The Importance of Sex in the Discovery of Colorectal Cancer Prognostic Biomarkers," International Journal of Molecular Sciences, vol. 22, no. 3, 2021.

[24]

Y. Cheng et al., "Comparison of serum exosome isolation methods on co-precipitated free microRNAs.," PeerJ, vol. 8, 2020.

[25]

L. Hases et al., "High-fat diet and estrogen impacts the colon and its transcriptome in a sex-dependent manner," Scientific Reports, vol. 10, 2020.

[26]

L. Hases et al., "Intestinal estrogen receptor beta suppresses colon inflammation andtumorigenesis in both sexes," Cancer Letters, vol. 492, s. 54-62, 2020.

[27]

J. L. A. Voskuil et al., "The Antibody Society's antibody validation webinar series," mAbs, vol. 12, no. 1, 2020.

[28]

J. Wang et al., "A miR-206 regulated gene landscape enhances mammary epithelial differentiation.," Journal of Cellular Physiology, vol. 234, no. 12, s. 22220-22233, 2019.

[29]

B. Katona et al., "Antibody Validation Strategy for Nuclear Receptors.," Methods in Molecular Biology, vol. 1966, s. 79-99, 2019.

[30]

F. Mesmar et al., "Clinical candidate and genistein analogue AXP107-11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein-coupled estrogen receptor signaling," Cancer Medicine, vol. 8, no. 18, s. 7705-7719, 2019.

[31]

A. Ibrahim et al., "Colitis-induced colorectal cancer and intestinal epithelial estrogen receptor beta impact gut microbiota diversity," International Journal of Cancer, vol. 144, no. 12, s. 3086-3098, 2019.

[32]

D. Zheng et al., "Sexual dimorphism in the incidence of human cancers," BMC Cancer, vol. 19, no. 1, 2019.

[33]

F. L. Monteiro et al., "The histone H2A isoform Hist2h2ac is a novel regulator of proliferation and epithelial-mesenchymal transition in mammary epithelial and in breast cancer cells.," Cancer Letters, vol. 396, s. 42-52, 2019.

[34]

A. C. Berger et al., "A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.," Cancer Cell, vol. 33, no. 4, s. 690-705.e9, 2018.

[35]

D. Zheng et al., "Regulation of sex hormone receptors in sexual dimorphism of human cancers," Cancer Letters, vol. 438, s. 24-31, 2018.

[36]

F. Danielsson et al., "Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia," Oncotarget, vol. 9, no. 28, s. 19730-19744, 2018.

[37]

R. Ma et al., "Estrogen Receptor β as a Therapeutic Target in Breast Cancer Stem Cells.," Journal of the National Cancer Institute, vol. 109, no. 3, s. 1-14, 2017.

[38]

M. Simon et al., "Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant," PLOS ONE, vol. 12, no. 2, 2017.

[39]

S. Andersson et al., "Insufficient antibody validation challenges oestrogen receptor beta research," Nature Communications, vol. 8, 2017.

[40]

C. Williams et al., "Estrogen receptor beta as target for colorectal cancer prevention," Cancer Letters, vol. 372, no. 1, s. 48-56, 2016.

[41]

T. Nguyen-Vu et al., "Estrogen receptor beta reduces colon cancer metastasis through a novel miR-205-PROX1 mechanism," Oncotarget, vol. 7, no. 27, s. 42159-42171, 2016.

[42]

R. Y. Reins et al., "Microarray Analysis of Vitamin D Treated Human Corneal Epithelial Cells," Investigative Ophthalmology and Visual Science, vol. 57, no. 12, 2016.

[43]

J. Zhu et al., "RING finger protein 31 promotes p53 degradation in breast cancer cells," Oncogene, vol. 35, no. 15, s. 1955-1964, 2016.

[44]

R. Y. Reins et al., "Vitamin D Induces Global Gene Transcription in Human Corneal Epithelial Cells : Implications for Corneal Inflammation," Investigative Ophthalmology and Visual Science, vol. 57, no. 6, s. 2689-2698, 2016.

[45]

P. Dey et al., "Estrogen Receptor beta 2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1 alpha in Prostate Cancer," PLOS ONE, vol. 10, no. 5, 2015.

[46]

M. Bondesson et al., "Estrogen receptor signaling during vertebrate development," Biochimica et Biophysica Acta. Gene Regulatory Mechanisms, vol. 1849, no. 2, s. 142-151, 2015.

[47]

P. Jonsson et al., "Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically Relevant lncRNAs in Breast Cancer," Molecular Endocrinology, vol. 29, no. 11, 2015.

[48]

E. Tsouko et al., "miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene," Carcinogenesis, vol. 36, no. 9, s. 1051-1060, 2015.

[49]

A. Katchy et al., "Coexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive manner," Toxicological Sciences, vol. 138, no. 1, s. 21-35, 2014.

[50]

M. L. Dória et al., "Fatty acid and phospholipid biosynthetic pathways are regulated throughout mammary epithelial cell differentiation and correlate to breast cancer survival," The FASEB Journal, vol. 28, no. 10, s. 4247-64, 2014.

[51]

C. Zhao et al., "Genome-wide profiling of AP-1-regulated transcription provides insights into the invasiveness of triple-negative breast cancer.," Cancer Research, vol. 74, no. 14, s. 3983-3994, 2014.

[52]

C. Williams et al., "Gestational bisphenol A exposure and testis development," Endocrine disruptors, vol. 2, no. 1, 2014.

[53]

A. Katchy och C. Williams, "Profiling of estrogen-regulated microRNAs in breast cancer cells.," Journal of Visualized Experiments, no. 84, 2014.

[54]

P. Jonsson, A. Katchy och C. Williams, "Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.," Endocrine-Related Cancer, vol. 21, no. 2, s. 143-160, 2014.

[55]

J. Zhu et al., "The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.," Oncogene, vol. 33, no. 34, s. 4340-4351, 2014.

[56]

J. Wang et al., "miR-206 inhibits cell migration through direct targeting of the actin-binding protein coronin 1C in triple-negative breast cancer," Molecular oncology, vol. 8, no. 8, s. 1690-702, 2014.

[57]

K. Edvardsson et al., "Estrogen receptor β expression induces changes in the microRNA pool in human colon cancer cells," Carcinogenesis, vol. 34, no. 7, s. 1431-41, 2013.

[58]

T. Nguyen-Vu et al., "Liver × receptor ligands disrupt breast cancer cell proliferation through an E2F-mediated mechanism," Breast Cancer Research, vol. 15, no. 3, 2013.

[59]

C. Williams och C.-Y. Lin, "Oestrogen receptors in breast cancer : basic mechanisms and clinical implications," ecancermedicalscience, vol. 7, no. 1, 2013.

[60]

D. N. Krementsov et al., "Studies in experimental autoimmune encephalomyelitis do not support developmental bisphenol a exposure as an environmental factor in increasing multiple sclerosis risk," Toxicological Sciences, vol. 135, no. 1, s. 91-102, 2013.

[61]

A. Katchy et al., "Estradiol-activated estrogen receptor α does not regulate mature microRNAs in T47D breast cancer cells.," Journal of Steroid Biochemistry and Molecular Biology, vol. 128, no. 3-5, s. 145-53, 2012.

[62]

P. Dey et al., "Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3," Molecular Endocrinology, vol. 26, no. 12, s. 1991-2003, 2012.

[63]

K. Dahlman-Wright et al., "Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells," Carcinogenesis, vol. 33, no. 9, s. 1684-91, 2012.

[64]

A. Ehrlund et al., "Knockdown of SF-1 and RNF31 affects components of steroidogenesis, TGFβ, and Wnt/β-catenin signaling in adrenocortical carcinoma cells.," PloS one, vol. 7, no. 3, s. e32080, 2012.

[65]

E. Aydoğdu et al., "MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer.," Carcinogenesis, vol. 33, no. 8, s. 1502-11, 2012.

[66]

K. Edvardsson et al., "Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.," Molecular Endocrinology, vol. 25, no. 6, s. 969-79, 2011.

[67]

C. P. Alvarez-Baron et al., "The two-pore domain potassium channel KCNK5 : induction by estrogen receptor alpha and role in proliferation of breast cancer cells.," Molecular Endocrinology, vol. 25, no. 8, s. 1326-36, 2011.

[68]

C. Williams et al., "Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression.," Breast cancer research : BCR, vol. 11, no. 3, s. R26, 2009.

[69]

J. Hartman et al., "Tumor repressive functions of estrogen receptor beta in SW480 colon cancer cells," Cancer Research, vol. 69, no. 15, s. 6100-6, 2009.

[70]

C. Williams et al., "A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells.," Oncogene, vol. 27, no. 7, s. 1019-1032, 2008.

[71]

P. Svensson et al., "Gene array identification of Ipf1/Pdx1(-/-) regulated genes in pancreatic progenitor cells," BMC Developmental Biology, vol. 7, 2007.

[72]

C. Williams et al., "Catalog of gene expression in adult neural stem cells and their in vivo microenvironment," Experimental Cell Research, vol. 312, no. 10, s. 1798-1812, 2006.

[73]

K. Richter et al., "Global gene expression analyses of hematopoietic stem cell-like cell lines with inducible Lhx2 expression," BMC Genomics, vol. 7, s. 75, 2006.

[74]

A. E. Persson et al., "The mutagenic effect of ultraviolet-A1 on human skin demonstrated by sequencing the p53 gene in single keratinocytes.," Photodermatology, Photoimmunology & Photomedicine, vol. 18, no. 6, s. 287-293, 2002.

[75]

C. Williams et al., "A high frequency of sequence alterations is due to formalin fixation of archival specimens.," American Journal of Pathology, vol. 155, no. 5, 1999.

[76]

J. Odeberg et al., "Context-dependent Taq-polymerase-mediated nucleotide alterations, as revealed by direct sequencing of the ZNF189 gene : implications for mutation detection.," Gene, vol. 235, no. 1-2, 1999.

[77]

A. Yngveson et al., "p53 Mutations in lung cancer associated with residential radon exposure.," Cancer Epidemiology, Biomarkers and Prevention, vol. 8, no. 5, 1999.

[78]

C. Williams et al., "Assessment of sequence-based p53 gene analysis in human breast cancer : messenger RNA in comparison with genomic DNA targets.," Clinical Chemistry, vol. 44, no. 3, 1998.

[79]

C. Williams et al., "Clones of normal keratinocytes and a variety of simultaneously present epidermal neoplastic lesions contain a multitude of p53 gene mutations in a xeroderma pigmentosum patient.," Cancer Research, vol. 58, no. 11, 1998.

[80]

J. Odeberg et al., "Cloning and characterization of ZNF189, a novel human Krüppel-like zinc finger gene localized to chromosome 9q22-q31.," Genomics, vol. 50, no. 2, s. 213-21, 1998.

[81]

A. Ahmadian et al., "Genetic instability in the 9q22.3 region is a late event in the development of squamous cell carcinoma.," Oncogene, vol. 17, no. 14, 1998.

[82]

Z. P. Ren et al., "Benign clonal keratinocyte patches with p53 mutations show no genetic link to synchronous squamous cell precancer or cancer in human skin," American Journal of Pathology, vol. 150, no. 5, s. 1791-803, 1997.

[83]

F. Pontén et al., "Genomic analysis of single cells from human basal cell cancer using laser-assisted capture microscopy.," Mutation research, vol. 382, no. 1-2, 1997.

[84]

F. Pontén et al., "Molecular pathology in basal cell cancer with p53 as a genetic marker.," Oncogene, vol. 15, no. 9, 1997.

[85]

C. Berg et al., "Direct solid-phase sequence analysis of the human p53 gene by use of multiplex polymerase chain reaction and alpha-thiotriphosphate nucleotides.," Clinical Chemistry, vol. 41, no. 10, s. 1461-6, 1995.

Kapitel i böcker

[86]

D. E. Frigo, M. Bondesson och C. Williams, "Nuclear receptors : from molecular mechanisms to therapeutics," i Exploring Nuclear Receptors, Williams, C Bondesson, M Frigo, DE red., : Portland Press Ltd., 2021, s. 847-856.

Icke refereegranskade

Artiklar

[87]

P. Giovannelli, P. Ramaraj och C. Williams, "Editorial : Role of Sex Steroids and Their Receptor in Cancers," Frontiers in Endocrinology, vol. 13, 2022.

[88]

L. Hases et al., "Intestinal estrogen receptor beta suppresses colon inflammation and tumorigenesis in both sexes," Cancer Research, vol. 80, no. 16, 2020.

[89]

C. Gnann et al., "Deep immunological profiling of the murine brain and spleen after high fat diet by CODEX multiplexed imaging.," Molecular Biology of the Cell, vol. 29, no. 26, 2018.

Kapitel i böcker

[90]

L. Hases, A. Archer och C. Williams, "ERβ and Inflammation," i Advances in Experimental Medicine and Biology, : Springer Nature, 2022, s. 213-225.

[91]

A. Katchy och C. Williams, "Expression Profiles of Estrogen-Regulated MicroRNAs in Breast Cancer Cells," i Methods in Molecular Biology : The Estrogen Receptors, Kathleen M. Eyster red., : Springer, 2016.